Search for: "AstraZeneca Inc."
Results 61 - 80
of 340
Sorted by Relevance
|
Sort by Date
12 Jun 2008, 4:45 am
Omeprazole is the active ingredient in Prilosec ®, which is marketed by Plaintiffs-Appellants Astrazeneca, AB, Aktiebolaget Hassle, KBI-E, Inc., KBI, Inc., and Astrazeneca LP (Astrazeneca) for the treatment of gastric and duodenal ulcers, and which acts by inhibiting the production of gastric acid. [read post]
7 Jun 2010, 3:03 pm
Zeneca, Inc., the US District Court of Delaware granted AstraZeneca's motion to dismiss plaintiffs' amended complaint for failure to state claims of consumer fraud, unjust enrichment, and negligent misrepresentation. [read post]
17 Jul 2012, 4:40 am
Here is the decision in Sandoz, Inc. v. [read post]
25 Jun 2007, 2:04 am
Supreme Court on Monday [June 25, 2007] turned away a challenge to a "reverse payments" deal between an AstraZeneca PLC unit and a Barr Pharmaceuticals Inc. unit to delay marketing of a generic breast-cancer drug.The rejection came after the U.S. [read post]
4 Nov 2010, 6:14 am
” Golden Blount, Inc. v. [read post]
27 Feb 2015, 5:02 am
AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act. [read post]
29 Jun 2018, 12:21 pm
(“Impax”), AstraZeneca AB, and AstraZeneca UKLimited (together, “AstraZeneca”), and entering an injunctionagainst Lannett pursuant to 35 U.S.C. [read post]
30 Jun 2014, 4:23 am
PepsiCo, Inc. [read post]
22 May 2015, 10:38 am
They claimed damages under the cross undertaking given by AstraZeneca, seeking £32 million in respect of their losses.The law on the calculation of damages under a cross-undertakingIn his January 2014 judgment, Sales J referred to the judgment of Norris J in Les Laboratoires Servier v Apotex Inc [2008] EWC 2347, [2009] FSR 3 as explaining the general principles to be applied when assessing the damages payable under a cross-undertaking. [read post]
21 Nov 2006, 9:58 am
Medtronic AVE, Inc., 339 F.3d 1352, 1363 (Fed. [read post]
17 Feb 2010, 8:00 am
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
13 May 2010, 6:22 am
Zeneca, Inc., No. 05-075-ER, Slip op. [read post]
13 Jan 2009, 8:41 am
800 Adept, Inc. v. [read post]
13 Feb 2011, 9:08 pm
Astrazeneca... [read post]
27 Oct 2009, 10:40 am
Nutrinova, Inc. [read post]
20 Dec 2012, 12:20 pm
Apotex Corp. is a United States affiliate of the Canadian Company Apotex Inc. [read post]
1 Feb 2022, 1:22 pm
Mylan Pharmaceuticals Inc., Docket No. 21-01729 (Fed. [read post]
5 Aug 2016, 2:10 pm
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
27 Feb 2012, 3:30 am
AstraZeneca Pharmaceuticals, LP, No. 1:10CV104-SA-JAD, 2010 WL 3951906 (N.D. [read post]
26 Apr 2007, 2:32 am
BusinessWeek notes another Congressional hearing on patent reform will occur on April 26, with testimony from Kevin Sharer, chief executive of biotech company Amgen Inc.; Anthony Peterman, patent counsel for computer manufacturer Dell Inc.; and Gary Griswold, president and chief counsel of intellectual property at 3M Co.Dell Inc. is a member of the Coalition for Patent Fairness, comprised mainly of IT companies strongly seeking patent reform (including Amazon.com, Apple,… [read post]
